Porro, Fabiola
Bortolussi, Giulia
Barzel, Adi
De Caneva, Alessia
Iaconcig, Alessandra
Vodret, Simone
Zentilin, Lorena
Kay, Mark A
Muro, Andrés F https://orcid.org/0000-0002-9628-0494
Funding for this research was provided by:
HHS|National Institutes of Health (R01 HL064274)
Article History
Received: 24 January 2017
Revised: 27 June 2017
Accepted: 4 July 2017
First Online: 27 July 2017
Conflict of interest
: M.A.K. and A.B. are shareholders for LogicBio Therapeutics that has licensed the GeneRide technology from Stanford University.